Sergey A. Loparev

Sergey A. Loparev

Department Of Urology, City Polyclinic No. 3, Vladivostok, Russia.

Direct Impact

Concepts for which Sergey A Loparev has direct influence:

overactive bladder
oab symptoms
elderly women
urinary incontinence
antimuscarinic drugs
cognitive functions
higher dosage

External impact

Concepts related to the work of other authors for which Sergey A Loparev has influence:

overactive bladder
detrusor overactivity
urinary incontinence
void measurements
minimum standards
benign prostatic hyperplasia
electrical stimulation

Prominent publications by Sergey A. Loparev

KOL-Index: 34 AimOur aim was to determine the efficiency of the Medication Compliance Self-Report Inventory (MASRI) in self-reporting antimuscarinic drug treatment compliance among women with urinary incontinence (UI).Materials and methodsThe study assessed 347 women aged 18–65 (averaging 49.7) years with more than one urinary incontinence (UI) episode per day. Treatment compliance was tested at the ...
Known for
Methodsthe | Spearman | Compliance Antimuscarinic | Percentage Noncompliant
KOL-Index: 28 AIM: The aim of this work was to study the factors affecting the stability of working patients in antimuscarinic (AM) drug treatment. BACKGROUND: The prevalence of urge urinary incontinence (UUI) is an average of between 8.2% and 16.0% of the population. UUI is a condition that adversely affects the health-related quality of life. The first-line therapy in managing UUI is AM treatment. ...
Known for
Compliance Working | 30-Day Break | Overactive Bladder - Short | 379
KOL-Index: 21 OBJECTIVE: To increase the safety and effectiveness of treatments for overactive bladder (OAB) with moderate symptoms in elderly patients. PATIENTS AND METHODS: Patients were examined at the Urodynamic Department of the Regional Diagnostic Center (Vladivostok, Russian Federation) from September 1, 2012 to December 31, 2012. The assignment of patients [n = 177, average age 69. 4 years, 98 ...
Known for
Bladder Diaries | Moderate Dysfunction | Vladivostok | Urodynamic Examination
KOL-Index: 19 PURPOSE: Study of validity of the Medication Adherence Self-Report Inventory (MASRI) for use in clinical practice to treat patients with benign prostatic obstruction (BPO) accompanied with overactive bladder (OAB) symptoms. METHODS: During 12 weeks of the randomized study, 452 patients with BPO and OAB symptoms (mean age of 61.3 (12.7)) were studied for adherence to the treatment with ...
Known for
Oab Awareness Tool | Lower Urinary Tract | 452 | Diaries
KOL-Index: 17 Objective: We studied the rationale for using standard and increased dosages of solifenacin and trospium against overactive bladder (OAB) symptoms of different severity among elderly patients. Methods: A total of 327 patients took part in the study: 199 women and 128 men older than 65 years (median age 69.1). The state of the lower urinary tracts was estimated by cystometry, ICIQ-SF and ...
Known for
Uui Severe | Symptoms Severity | Xerostomia | Intolerable
KOL-Index: 17 PURPOSE: To improve the long-term efficiency of the pharmacologic management of overactive bladder (OAB) in elderly women. METHODS: The study comprised 229 women (mean age, 66.3 years; range, 65-77 years) with urodynamically and clinically confirmed OAB. All patients received the most effective treatment regimen based on the data obtained in the initial part of the study (trospium 60 mg/day ...
Known for
Trospium Solifenacin | Method Maintenance | Antimuscarinics | Long-Term Efficiency
KOL-Index: 16 MATERIAL AND METHODS: 313 patients, 196 women and 117 men over 65 (average age 68.6) were included in this study. All patients underwent urodynamic examination before enrollment and after the study was completed. For clinical evaluation of LUT state ICIQ-SF questionnaires and bladder diaries were used. Patients with moderate (А, n = 155) and severe (В, n = 158) symptoms of OAB. Each group ...
Known for
Trospium Solifenacin | 45-60 | Subgroups Severe | Oab Elderly
KOL-Index: 11 Increase of effectiveness of treatment for severe overactive bladder (OAB) symptoms in patients 40–65 and 66–80 years of aged with combined antimuscarinic drugs. This placebo-controlled longitudinal study was performed on the basis of Regional Diagnostic Centre (Vladivostok city, Russian Federation) from 1 June 2011 to 30 December 2012. Assignment of patients (n = 299, average age: 67·1; ...
Known for
Double-Dosed Antimuscarinics | Standard-Dosed Trospium | Treated Dosed | Urodynamic Indexes
KOL-Index: 11 OBJECTIVES: To study the effectiveness and safety of combined standard-dosed Solifenacin and Trospium for management of symptoms of overactive bladder (OAB) in elderly patients after the treatment with Tamsulosin. PATIENTS AND METHODS: A total of 417 men over 50 years of age (average age 57.9 (8.3)) with diagnosed prostatic obstruction (score 8-19 according to I-PSS), who had not taken ...
Known for
I-Pss | Absolute Number | 417 | Anti-Muscarinic Drugs
KOL-Index: 10 AIM: To study the cognitive functions and health-related quality of life (HRQoL) in individuals taking a combination of tamsulosin and solifenacin in a higher dosage. METHODS: All patients (n = 262) were assigned to group A (N = 93, tamsulosin 0.4 mg + solifenacin 10 mg per day), group B (N = 83, tamsulosin 0.4 mg + solifenacin 20 mg), and control group C (N = 86; tamsulosin ...
Known for
Active Bladder Awareness Tool | Combination Solifenacin | California Verbal Learning Test | Values Cognitive

Department of Urology, City Polyclinic No. 3, Vladivostok, Russia.

© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172